Home › Research › Topics › anti-tau
anti-tau
8 studies tagged anti-tau, dated 2002-08-30 to 2023-09-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model 2023-09-01
- Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer's Therapeutics 2020-01-21
- AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy 2017-04-17
Studies
8 studies carry this tag.
Date range
2002 to 2023
Top journals
- Acta neuropathologica 1
- Human vaccines 1
- International journal of molecular sciences 1
- Journal of Alzheimer's disease : JAD 1
- Neuroscience letters 1
8 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Misfolded proteins in Alzheimer's disease and Parkinson's disease follow a well-defined connectomics-based spatial progression.
-
Aging-associated neurodegenerative diseases, which are characterized by progressive neuronal death and synapses loss in human brain, are rapidly growing affecting millions of people globally.
-
41/100
Tauopathies are characterized by the progressive accumulation of hyperphosphorylated, aggregated forms of tau.
-
Alzheimer's disease (AD) represents the most frequent neurodegenerative disease of the human brain worldwide.
-
Current drugs for treatment of mild to severe dementia of the Alzheimer's type include cholinesterase inhibitors and the NMDA non-competitive receptor antagonist memantine.
-
36/100
Alzheimer's disease (AD) is a progressive, neurodegenerative disease characterized by extracellular deposits of amyloid beta (Aβ) protein and intracellular neurofibrillary tangles of hyperphosphorylated tau protein.
-
The aggregation and accumulation of the microtubule-associated protein (Tau) is a pathological hallmark of Alzheimer's disease (AD) and many neurodegenerative diseases.
-
The rabbit polyclonal anti-tau phospho-specific Ser262 antibody (577814 Calbiochem) recognizes disease-specific band patterns on Western blots of sarkosyl-insoluble fractions in Alzheimer's disease (AD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), argyrophilic grain disease (AGD) and Pick's disease (PiD): four bands of 74/72, 68, 64 and 60 kDa in AD, two bands of 68 and 64 kDa in PSP, CBD and AGD, and two bands of 64 and 60 kDa in PiD.